This article is more than 5 years old. Information may no longer be current.

Ketorolac has little effect on consecutive hyperopia post-LASIK

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ketorolac does not improve consecutive hyperopia after LASIK for myopia and compound myopic astigmatism when compared with a matched control group, according to a study.

Naazli M. Shaikh, MD, and colleagues at the Henry Ford Health Systems in Troy, Mich., analyzed data from 72 eyes of 51 patients who had undergone LASIK and experienced consecutive hyperopia of at least +0.5 D within the first postoperative week. Of the patients, 37 were treated with ketorolac and followed for 2 months; the remaining 35 were followed only.

The mean start time for ketorolac treatment was 9 days postop. Mean treatment time was 24.5 days, with a range of 10 to 63 days. On average, treated patients were 9 years older than those in the control group.

No significant difference in the overall rate of regression between the two groups existed during the follow-up period.

The study is published in the May issue of Cornea.